{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:16:38Z","timestamp":1761164198633,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","techvir.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Techniques in Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1053\/j.tvir.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T19:16:46Z","timestamp":1462475806000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery"],"prefix":"10.1053","volume":"19","author":[{"given":"Akshaar","family":"Brahmbhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib1","first-page":"e18","article-title":"Heart disease and stroke statistics\u20142011 update: A report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1053\/j.tvir.2016.04.007_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jvs.2009.01.035","article-title":"National trends in lower extremity bypass surgery, endovascular interventions, and major amputations","volume":"50","author":"Goodney","year":"2009","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jvs.2005.11.002","article-title":"Trends, complications, and mortality in peripheral vascular surgery","volume":"43","author":"Nowygrod","year":"2006","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib5","first-page":"81","article-title":"Inter-society consensus for the management of peripheral arterial disease","volume":"26","author":"Norgren","year":"2007","journal-title":"Int Angiol"},{"issue":"12","key":"10.1053\/j.tvir.2016.04.007_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/j.tvir.2016.04.007_bib7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.CIR.30.5.654","article-title":"Transluminial treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application","volume":"30","author":"Dotter","year":"1964","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jvir.2014.12.013","article-title":"Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease","volume":"26","author":"Baerlocher","year":"2015","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"10.1053\/j.tvir.2016.04.007_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: The IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib10","first-page":"191","article-title":"Unique demands of the femoral anatomy and pathology and the need for unique interventions","volume":"54","author":"Otsuka","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"9","key":"10.1053\/j.tvir.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","article-title":"Endovascular intervention for peripheral artery disease","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res"},{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.avsg.2012.09.005","article-title":"In-stent restenosis in the superficial femoral artery","volume":"27","author":"Razzouk","year":"2013","journal-title":"Ann Vasc Surg"},{"issue":"9","key":"10.1053\/j.tvir.2016.04.007_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11936-015-0400-3","article-title":"Superficial femoral artery intervention: Creating an algorithmic approach for the use of old and novel (endovascular) technologies","volume":"17","author":"Rundback","year":"2015","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"3","key":"10.1053\/j.tvir.2016.04.007_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000006967","article-title":"Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis","volume":"92","author":"Yutani","year":"1999","journal-title":"Cardiology"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.kint.2015.12.019","article-title":"The molecular mechanisms of hemodialysis vascular access failure","volume":"89","author":"Brahmbhatt","year":"2016","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/heart.89.2.218","article-title":"In-stent stenosis: Pathology and implications for the development of drug eluting stents","volume":"89","author":"Bennett","year":"2003","journal-title":"Heart"},{"issue":"3","key":"10.1053\/j.tvir.2016.04.007_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.98.3.224","article-title":"Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses","volume":"98","author":"Komatsu","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.tvir.2016.04.007_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/heartjnl-2012-302945","article-title":"Drug-eluting balloon angioplasty for in-stent restenosis: A systematic review and meta-analysis of randomised controlled trials","volume":"99","author":"Indermuehle","year":"2013","journal-title":"Heart"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","article-title":"Vascular smooth muscle cell proliferation in restenosis","volume":"4","author":"Marx","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1053\/j.tvir.2016.04.007_bib20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0735-1097(88)80046-9","article-title":"Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients","volume":"12","author":"Nobuyoshi","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0735-1097(99)00486-6","article-title":"Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen","volume":"35","author":"Grewe","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1053\/j.tvir.2016.04.007_bib22","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.2353\/ajpath.2009.090152","article-title":"The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy","volume":"175","author":"Hayashi","year":"2009","journal-title":"Am J Pathol"},{"issue":"15","key":"10.1053\/j.tvir.2016.04.007_bib23","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1074\/jbc.M112.413542","article-title":"Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2\/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR","volume":"288","author":"Kilari","year":"2013","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1053\/j.tvir.2016.04.007_bib24","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1053\/j.tvir.2016.04.007_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.295.11.1253","article-title":"Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial","volume":"295","author":"Stone","year":"2006","journal-title":"J Am Med Assoc"},{"issue":"11","key":"10.1053\/j.tvir.2016.04.007_bib26","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jama.295.11.1264","article-title":"Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trial","volume":"295","author":"Holmes","year":"2006","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1053\/j.tvir.2016.04.007_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ahj.2011.11.019","article-title":"Five-year follow-up of the sirolimus-eluting stents vs vascular brachytherapy for bare metal in-stent restenosis (SISR) trial","volume":"163","author":"Alli","year":"2012","journal-title":"Am Heart J"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2012.07.017","article-title":"High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: The randomized ROTAXUS (rotational atherectomy prior to taxus stent treatment for complex native coronary artery disease) trial","volume":"6","author":"Abdel-Wahab","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1053\/j.tvir.2016.04.007_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/hc0502.103347","article-title":"Rotational atherectomy does not reduce recurrent in-stent restenosis: Results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST)","volume":"105","author":"vom Dahl","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1053\/j.tvir.2016.04.007_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcin.2014.05.006","article-title":"Lower extremity revascularization using directional atherectomy: 12-Month prospective results of the DEFINITIVE LE study","volume":"7","author":"McKinsey","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1053\/j.tvir.2016.04.007_bib31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvir.2012.10.004","volume":"24","author":"Saxon","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J Vasc Surg"},{"issue":"7","key":"10.1053\/j.tvir.2016.04.007_bib34","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0735-1097(00)00614-8","article-title":"Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo","volume":"35","author":"Herdeg","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ijc.20083","article-title":"Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature","volume":"110","author":"Strieth","year":"2004","journal-title":"Int J Cancer"},{"issue":"1-2","key":"10.1053\/j.tvir.2016.04.007_bib37","first-page":"79","article-title":"Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis","volume":"26","author":"Zhu","year":"2015","journal-title":"Biomed Mater Eng"},{"issue":"3-4","key":"10.1053\/j.tvir.2016.04.007_bib38","first-page":"197","article-title":"Antiproliferative stent coatings: Taxol and related compounds","volume":"3","author":"Herdeg","year":"1998","journal-title":"Semin Interv Cardiol"},{"issue":"25","key":"10.1053\/j.tvir.2016.04.007_bib39","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1073\/pnas.0400918101","article-title":"Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel","volume":"101","author":"Levin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib40","doi-asserted-by":"crossref","first-page":"e000117","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: Impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"issue":"3","key":"10.1053\/j.tvir.2016.04.007_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvn079","article-title":"FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation","volume":"79","author":"Giordano","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1053\/j.tvir.2016.04.007_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.coph.2011.03.006","article-title":"Inhibition of human in-stent restenosis: A molecular view","volume":"11","author":"Giordano","year":"2011","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"10.1053\/j.tvir.2016.04.007_bib44","first-page":"E599","article-title":"Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): Is it different from bare-metal stents and first-generation DES?","volume":"7","author":"Kuramitsu","year":"2015","journal-title":"J Thorac Dis"},{"issue":"11","key":"10.1053\/j.tvir.2016.04.007_bib45","doi-asserted-by":"crossref","first-page":"e113870","DOI":"10.1371\/journal.pone.0113870","article-title":"Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis","volume":"9","author":"Yamaji","year":"2014","journal-title":"PLoS One"},{"issue":"24","key":"10.1053\/j.tvir.2016.04.007_bib46","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","author":"Gray","year":"2010","journal-title":"Circulation"},{"issue":"1 Pt A","key":"10.1053\/j.tvir.2016.04.007_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-Year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1053\/j.tvir.2016.04.007_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1053\/j.tvir.2016.04.007_bib49","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.tvir.2016.04.007_bib50","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/hc3601.093987","article-title":"Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib51","first-page":"132","article-title":"Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model","volume":"83","author":"Yazdani","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1053\/j.tvir.2016.04.007_bib52","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jps.1085","article-title":"Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel","volume":"90","author":"Lovich","year":"2001","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1053\/j.tvir.2016.04.007_bib53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.RES.86.8.879","article-title":"Arterial paclitaxel distribution and deposition","volume":"86","author":"Creel","year":"2000","journal-title":"Circ Res"},{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e31820577df","article-title":"Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model","volume":"46","author":"Kelsch","year":"2011","journal-title":"Invest Radiol"},{"issue":"10","key":"10.1053\/j.tvir.2016.04.007_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcin.2009.07.007","article-title":"Clinical and angiographic results with the next-generation resolute stent system: A prospective, multicenter, first-in-human trial","volume":"2","author":"Meredith","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.tvir.2016.04.007_bib56","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.amjcard.2015.11.056","article-title":"Prognostic significance of polymer coatings in zotarolimus-eluting stents","volume":"117","author":"Iqbal","year":"2016","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9824","key":"10.1053\/j.tvir.2016.04.007_bib58","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: First-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1053\/j.tvir.2016.04.007_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jvir.2010.12.027","article-title":"Polymer-free paclitaxel-coated zilver PTX stents\u2014Evaluation of pharmacokinetics and comparative safety in porcine arteries","volume":"22","author":"Dake","year":"2011","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"10.1053\/j.tvir.2016.04.007_bib61","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jvir.2009.08.020","article-title":"Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model","volume":"20","author":"Nugent","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.tvir.2016.04.007_bib62","first-page":"23","article-title":"Targeted treatments for restenosis and vein graft disease","volume":"2012","author":"Thomas","year":"2012","journal-title":"ISRN Vasc Med"},{"issue":"6","key":"10.1053\/j.tvir.2016.04.007_bib63","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jvs.2014.01.014","article-title":"Pilot safety study of perivascular injection of tissue-engineered allogeneic aortic endothelial cells in patients undergoing minimally invasive peripheral revascularization","volume":"59","author":"Sevestre","year":"2014","journal-title":"J Vasc Surg"},{"issue":"16","key":"10.1053\/j.tvir.2016.04.007_bib64","first-page":"2025","article-title":"Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients","volume":"12","author":"Fuster","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1053\/j.tvir.2016.04.007_bib65","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jvs.2013.10.051","article-title":"Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization","volume":"59","author":"Owens","year":"2014","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000369480","article-title":"The development of carotid stent material","volume":"3","author":"He","year":"2015","journal-title":"Interv Neurol"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1148\/radiology.147.1.6828741","article-title":"Transluminal expandable nitinol coil stent grafting: Preliminary report","volume":"147","author":"Dotter","year":"1983","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1148\/radiology.147.1.6828742","article-title":"Nonsurgical placement of arterial endoprostheses: A new technique using nitinol wire","volume":"147","author":"Cragg","year":"1983","journal-title":"Radiology"},{"issue":"9","key":"10.1053\/j.tvir.2016.04.007_bib69","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2015.03.029","article-title":"Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt Model","volume":"8","author":"Otsuka","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1053\/j.tvir.2016.04.007_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jss.2006.07.035","article-title":"Sirolimus-eluting biodegradable poly-l-lactide stent for peripheral vascular application: A preliminary study in porcine carotid arteries","volume":"139","author":"Bunger","year":"2007","journal-title":"J Surg Res"},{"key":"10.1053\/j.tvir.2016.04.007_bib71","article-title":"Evidence for treating peripheral arterial diseases with biodegradable scaffolds","author":"Chu","year":"2015","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"7","key":"10.1053\/j.tvir.2016.04.007_bib72","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.tvir.2016.04.007_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbm.a.35570","article-title":"Biphasic responses of human vascular smooth muscle cells to magnesium ion","volume":"104","author":"Ma","year":"2016","journal-title":"J Biomed Mater Res A"},{"issue":"7","key":"10.1053\/j.tvir.2016.04.007_bib74","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.3390\/ijms12074250","article-title":"Biodegradable metals for cardiovascular stent application: Interests and new opportunities","volume":"12","author":"Moravej","year":"2011","journal-title":"Int J Mol Sci"}],"container-title":["Techniques in Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251616300075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251616300075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:53:41Z","timestamp":1761069221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089251616300075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1089251616300075"],"URL":"https:\/\/doi.org\/10.1053\/j.tvir.2016.04.007","relation":{},"ISSN":["1089-2516"],"issn-type":[{"type":"print","value":"1089-2516"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery","name":"articletitle","label":"Article Title"},{"value":"Techniques in Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.tvir.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}